Transcription of MULTIPLE MYELOMA (MM) - Celgene
{{id}} {{{paragraph}}}
Example: confidence
MULTIPLE MYELOMA (MM) - Celgene
Area of Research Phase 1 Phase 2 Phase 3 Post-Approval Research MULTIPLE MYELOMA (MM). REVLIMID (lenalidomide) . Relapsed/refractory .. Newly diagnosed .. Maintenance .. POMALYST /IMNOVID (US/EU).. (pomalidomide) Relapsed/refractory .. THALOMID /Thalidomide Celgene . (US/EU) (thalidomide) Newly diagnosed .. IMFINZI (durvalumab) a Relapsed/refractory, newly diagnosed* .. CC-122 .. BCMA CAR T (bb2121) b Relapsed/refractory .. BCMA CAR T (bb21217) b .. CC-220 Relapsed/refractory .. Citarinostat (ACY-241) Relapsed/refractory .. CC-92480 .. MYELODYSPLASTIC SYNDROMES (MDS). VIDAZA (azacitidine for injection) .. REVLIMID (lenalidomide) . Deletion 5q .. CC-486 Lower-risk .. Post hypomethylating agent (HMA) failure .. Luspatercept (ACE-536) c .. IMFINZI (durvalumab) a Post HMA failure .. Anti-CD47 Antibody: CC-90002 .. ACUTE MYELOID LEUKEMIA (AML). VIDAZA (azacitidine for injection) . AML (20%-30% blasts) (EU) .. AML (>30% blasts) (EU).
Area of Research Phase 1 Phase 2 Phase 3 Post-Approval Research C C F P- esear C- C- T T appr LYMPHOMA REVLIMID® (lenalidomide) Mantle cell lymphoma: Relapsed/refractory . . . . . . . . . . Diffuse large B-cell lymphoma (ABC subtype): First-line .
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
For pipeline, Approach to Pipeline Integrity Management, Pipeline, Procedures for Preventative Maintenance, Procedures for Preventative Maintenance Treatment, Frequently Asked Questions Concerning Pipeline, Frequently Asked Questions Concerning Pipeline Easements, Dischage Pipeline Density, Analysis of the US Biosimilars Development